Teladoc, Inc. (NYSE:TDOC) VP Mark Hirschhorn sold 5,000 shares of Teladoc stock in a transaction on Monday, January 9th. The shares were sold at an average price of $17.50, for a total value of $87,500.00. Following the transaction, the vice president now owns 250,887 shares in the company, valued at $4,390,522.50. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Mark Hirschhorn also recently made the following trade(s):

  • On Thursday, December 15th, Mark Hirschhorn sold 5,000 shares of Teladoc stock. The shares were sold at an average price of $16.60, for a total value of $83,000.00.
  • On Wednesday, November 16th, Mark Hirschhorn sold 10,000 shares of Teladoc stock. The shares were sold at an average price of $17.19, for a total value of $171,900.00.
  • On Thursday, November 10th, Mark Hirschhorn sold 5,000 shares of Teladoc stock. The shares were sold at an average price of $17.50, for a total value of $87,500.00.
  • On Monday, October 17th, Mark Hirschhorn sold 5,000 shares of Teladoc stock. The shares were sold at an average price of $15.52, for a total value of $77,600.00.

Shares of Teladoc, Inc. (NYSE:TDOC) opened at 17.90 on Friday. The stock has a 50 day moving average price of $17.33 and a 200 day moving average price of $17.19. The firm’s market cap is $823.97 million. Teladoc, Inc. has a 12 month low of $9.08 and a 12 month high of $19.53.

Teladoc (NYSE:TDOC) last announced its earnings results on Thursday, October 27th. The company reported ($0.33) EPS for the quarter, topping the consensus estimate of ($0.36) by $0.03. The business had revenue of $32.40 million for the quarter, compared to the consensus estimate of $32.29 million. Teladoc had a negative return on equity of 32.68% and a negative net margin of 69.15%. Teladoc’s revenue was up 62.0% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.35) EPS. On average, equities research analysts expect that Teladoc, Inc. will post ($1.43) EPS for the current year.

Insider Buying and Selling by Quarter for Teladoc (NYSE:TDOC)

TRADEMARK VIOLATION NOTICE: “Mark Hirschhorn Sells 5,000 Shares of Teladoc, Inc. (TDOC) Stock” was first posted by Daily Political and is owned by of Daily Political. If you are accessing this article on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The legal version of this article can be viewed at http://www.dailypolitical.com/2017/01/13/mark-hirschhorn-sells-5000-shares-of-teladoc-inc-tdoc-stock.html.

Several brokerages have recently issued reports on TDOC. Oppenheimer Holdings, Inc. set a $23.00 price target on Teladoc and gave the company a “buy” rating in a research report on Sunday, October 30th. Zacks Investment Research cut Teladoc from a “buy” rating to a “hold” rating in a research report on Wednesday. Canaccord Genuity began coverage on Teladoc in a research report on Wednesday, January 4th. They set a “buy” rating and a $24.00 price target on the stock. Chardan Capital reiterated a “buy” rating and set a $24.00 price target on shares of Teladoc in a research report on Sunday, December 4th. Finally, Cantor Fitzgerald began coverage on Teladoc in a research report on Thursday, January 5th. They set an “overweight” rating and a $25.00 price target on the stock. Two research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $23.07.

Hedge funds and other institutional investors have recently made changes to their positions in the company. US Bancorp DE increased its position in shares of Teladoc by 31.7% in the second quarter. US Bancorp DE now owns 7,507 shares of the company’s stock valued at $120,000 after buying an additional 1,805 shares during the last quarter. American International Group Inc. increased its position in shares of Teladoc by 109.4% in the second quarter. American International Group Inc. now owns 11,945 shares of the company’s stock valued at $191,000 after buying an additional 6,240 shares during the last quarter. Airain ltd acquired a new position in shares of Teladoc during the second quarter valued at approximately $200,000. UBS Asset Management Americas Inc. increased its position in shares of Teladoc by 9.5% in the third quarter. UBS Asset Management Americas Inc. now owns 12,050 shares of the company’s stock valued at $221,000 after buying an additional 1,050 shares during the last quarter. Finally, Credit Suisse AG increased its position in shares of Teladoc by 4.3% in the third quarter. Credit Suisse AG now owns 12,055 shares of the company’s stock valued at $221,000 after buying an additional 498 shares during the last quarter. 53.34% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Company Profile

Teladoc, Inc, together with its subsidiaries, is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company operates through health services segment. Its solution connects its Members, with its over 3,000 board-certified physicians and behavioral health professionals who treat a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

5 Day Chart for NYSE:TDOC

Receive News & Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related companies with MarketBeat.com's FREE daily email newsletter.